Turkish Journal of Oncology Turkish Society for Radiation Oncology
Article Open Access Volume 26 · Issue 4 · 2011 pp. 174–177

Intracranial metastasis from adenocarcinoma of prostate: case report

Gamze GÖKÖZ DOĞU1
1 Department of Medical Oncology, Kayseri Training and Research Hospital, Kayseri
2 Department of Medical Oncology, Erciyes University M.K. Dedeman Oncology Hospital, Kayseri
3 Department of Radiology, Erciyes University Faculty of Medicine, Kayseri
4 Department of Medical Oncology, Yıldırım Beyazıt Oncology Hospital, Ankara, all in Turkey
Published: 2011 Pubmed: 107873 Article ID: 795
PDF
Abstract
Although adenocarcinoma of the prostate has significant propensity
for metastatic involvement of the bone and other organ
systems it rarely invades the brain parenchyma. A 70-year-old
man with prostate cancer was admitted to the hospital because
of sudden onset of neurological signs. Computed tomography
scan demonstrated a large hyperdense dural metastasis with hyperostosis
in the left frontal region. Here we report a case of a
large dural based metastatasis from adenocarcinoma of the prostate,
clinically and radiographically mimicking a meningioma.
Additionally, in this case report the implications of dural-based
intracranial lesions in patients with prostate cancer is discussed
and the current literature for dural metastases is reviewed.

Keywords: Brain metastasis; computed tomography; meningioma; prostate cancer

Full text

Introduction

The proportion of prostate adenocarcinomas with metastasis at diagnosis is reported to be 30- 40%. On the other hand, in approximately 1% of patients with localized cancer, existing metastasis is missed at diagnosis.[] Cases of diffuse intracranial metastasis due to prostate adenocarcinoma are quite rare in the literature. Specifically, cases with hyperdense metastasis with cranial hyperostosis are extremely rare. Here we report a case of prostatic adenocarcinoma in which intracranial hyperdense lesions are detected radiologically with accompanying hyperostosis in the adjacent cranial bone. Additionally, the literature is reviewed for pathological conditions which may mimic dural metastases that should be considered in differential diagnosis.

Case Presentation

A 70-year-old male patient presented in the emergency room with signs of sudden onset left hemiplegia and aphasia. Of significance in his medical history was that he had undergone a transurethral resection in another hospital 3 years ago for prostatic adenocarcinoma. Postoperatively, the patient started receiving a combination of antiandrogen therapy with a GnRH agonist. Two years after the diagnosis the patient underwent cystoscopic drainage due to infravesical obstruction. Bone scintigraphy performed at that time demonstrated diffuse metastasis and thus zoledronic acid was added to the patient’s therapy. After six months bilateral orchiectomy was also performed. He was on antiandrogen therapy for approximately 6 months when he was referred to our hospital, three years after the initial diagnosis, due to acute left hemiplegia and aphasia, otherthan that, the patient’s physical examination did not reveal any significant pathology.

Computed tomography (CT) demonstrated bilateral intracranial extra-axial hyperdense lesions. Computed tomography scan with intravenous contrast agent revealed diffuse involvement of lesions in the left frontal region leading to hyperostosis in the adjacent cranial bone (Figures 1 and 2). A well circumscribed mass lesion causing vasogenic oedema in the surrounding tissue was detected in the insula and basal ganglia regions of the right hemispheric area. Anti-oedema therapy with concurrent radiotherapy was started. Palliative radiotherapy received WBRT in daily 2 Gy fractions to a total of 30 Gy in 10 fractions over 2 weeks. The patient started speaking and moving his extremities by the end of the first month of therapy.

Fig 1: Computed tomographic images of a cerebral mass simulating meningioma, which was localized in left frontal hemisphe1ric region and caused hyperostosis in the adjacent cranial bone.

Fig 2: Computed tomographic images of a cerebral mass which was localized in right hemispheric region and caused a vasogenic oedema effect with contrast media enhancement.

Discussion

Prostatic adenocarcinoma is the most common type of cancer seen in men over 50 years of age. Usually the involvement of the central nervous system is the result of spinal cord compression following metastasis to the bone.[] Prostatic adenocarcinoma may exhibit a quite different metastatic behaviour compared to other urogenital system tumors. Local invasion precedes the involvement of pelvic lymph nodes. Besides lymphatic circulation, prostate cancer may also spread through the Batson’s plexus or the pelvic venous plexus which is associated with the systemic circulation.[]

Brain metastasis in the adenocarcinoma of the prostate is seen only in 1% of all cases and subdural and parenchymal metastasis is reported to be rare due to the barrier effect of the dura.[-] In autopsy series, the incidence of cranial involvement in malignancies is reported as 17%. Isolated meningial involvement constitutes approximately 1% of these lesions.[] Although meningiomas can be differentiated by their clinical and radiological properties, some other pathological conditions may mimic these lesions. Benign, inflammatory, infectious and also malign lesions may lead to this clinical condition. Ependimomas, xantoastrositomas, plasmocytomas, lymphomas, leiomyosarcomas, cancers of the prostate, colon, gall bladder, lung, kidney, breast and thyroid gland, adenoid cystic cancers, neuroblastomas, melanomas, cancers with unknown primary tumors, chondromas and solitary fibrous tumors, are among these pathological conditions.[-] Additionally, other relatively rare conditions including actinomycosis tuberculosis, sarcoidosis, subdural hematoma, HIV infection, and other non-malign causes such as Rosai-Dorfman’s and Castleman’s disease may lead to this clinical condition. Meningioma-like lesions are rarely seen in old patients with prostatic cancer. Classical incidental meningioma and metastatic spread due to other malignancies is even rarer in this age group. [,] The presence of brain metastasis in patients with prostatic adenocarcinoma is usually accompanied by other organ metastases and is associated with a poor prognosis.

In conclusion, not only metastatic tumors, but also non-malignant conditions should be considered in cancer patients presenting with neurological signs and a cerebral mass simulating meningioma. Biopsy should be performed for differential diagnosis, as appropriate. In this case biopsy could not be performed since the patient did not give consent. The patient died 4 months after the development of the brain metastasis.

References

Arrizabalaga Moreno M, García González JI, Mora Durvan M, Díez Rodríguez JM, Esteban Artiaga R, Navarro Sebastián J, et al. Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis. [Article in Spanish] Actas Urol Esp 1997;21(8):724-36. [Abstract] Catane R, Kaufman J, West C, Merrin C, Tsukada Y, Murphy GP. Brain metastasis from prostatic carcinoma. Cancer 1976;38(6):2583-7. Debois JM. The anatomy and clinics of metastatic cancer. Hingham, MA: Kluwer Academic Publishers; 2002. p. 482. Cheng CL, Greenberg J, Hoover LA. Prostatic adenocarcinoma metastatic to chronic subdural hematoma membranes. Case report. J Neurosurg 1988;68(4):642-4. Penley MW, Kim YC, Pribram HF. Subdural metastases from prostatic adenocarcinoma. Surg Neurol 1981;16(2):131-4. Demierre B, Berney J. Intracranial metastases of cancer of the prostate. [Article in French] Neurochirurgie 1983;29(2):143-9. [Abstract] SIMIONESCU MD. Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960;17:361-73. Tagle P, Villanueva P, Torrealba G, Huete I. Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol 2002;58(3-4):241-5. Fink LH. Metastasis of prostatic adenocarcinoma simulating a falx meningioma. Surg Neurol 1979;12(3):253-8. Franco E, Gil-Néciga E, Cano G, Espinosa R, Ruiz- Mateos R, Ollero M. Sphenoid metastasis mimicking a meningioma as the initial feature of adenocarcinoma of the prostate. [Article in Spanish] Rev Neurol 1999;29(10):929-32. [Abstract] Lippman SM, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, et al. Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature. Neurosurgery 1986;19(5):820-3. Kwee IL, Nakada T, St John JN. Triple fossa metastasis of prostate cancer. Neurosurgery 1983;13(5):584-6. Kleinschmidt-DeMasters BK. Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 2001;125(7):880-7. Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum Pathol 2002;33(12):1211-26. Ohba S, Kurokawa R, Yoshida K, Kawase T. Metastatic adenocarcinoma of the dura mimicking petroclival meningioma--case report. Neurol Med Chir (Tokyo) 2004;44(6):317-20. Negron-Soto JM, Kilpatrick M, Irani N, Castillo M. Case of the season: metastatic pituitary carcinoma mimicking meningioma. Semin Roentgenol 2004;39(4):519-21. Higuchi M, Fujimoto Y, Miyahara E, Ikeda H. Isolated dural metastasis from colon cancer. Clin Neurol Neurosurg 1997;99(2):135-7. Kuroki T, Matsumoto M, Kushida T, Ohtsuka T, Uchino M, Nishikawa H. Nontraumatic subdural hematoma secondary to dural metastasis of lung cancer: case report and review of the literature. [Article in Japanese] No Shinkei Geka 1994;22(9):857-62. [Abstract] Kaur A, Harrigan MR, MeKeever PE, Ross DA. Adenoid cystic carcinoma metastatic to the dura: report of two cases. J Neurooncol 1999;44(3):267-73. Richiello A, Sparano L, Del Basso De Caro ML, Russo G. Dural metastasis mimicking falx meningioma. Case report. J Neurosurg Sci 2003;47(3):167-71. Varlet G, N’Dri Oka D, Kakou M, Echimane A, Ba Zézé V. Secondary subdural hematoma in dural metastasis of prostatic adenocarcinoma. [Article in French] Rev Neurol (Paris) 2001;157(12):1543-5. [Abstract] Villano JL, Ryan CW. Patients presenting with CNS lesions. Case 2. Subdural presentation of recurrent breast cancer. J Clin Oncol 2003;21(21):4060-2. Penley MW, Kim YC, Pribram HF. Subdural metastases from prostatic adenocarcinoma. Surg Neurol 1981;16(2):131-4. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 1983;52(12):2349-54. Bergmann M, Puskas Z, Kuchelmeister K. Subdural hematoma due to dural metastasis: case report and review of the literature. Clin Neurol Neurosurg 1992;94(3):235-40. Ludwig HC, Behnke J, Markakis E. Brain metastases in neurosurgery: indications, surgical procedures and outcome. Anticancer Res 1998;18(3C):2215-8.
Previous article Next article

Article information

6,595 Views
1,820 Downloads
View / Download PDF

Current Issue Vol 26 · Iss 4

Turkish Journal of Oncology – Issue cover
Submit manuscript
Most read & early access
Click an article to open abstract.
No early access articles.
View all articles